Skip to main content
Erschienen in: Clinical Rheumatology 8/2009

01.08.2009 | Brief Report

Mean platelet volume in children with familial Mediterranean fever

verfasst von: Balahan Makay, Zeynep Türkyilmaz, Erbil Ünsal

Erschienen in: Clinical Rheumatology | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Familial Mediterranean fever (FMF) is the most common inherited periodic fever syndrome characterized by recurrent episodes of serositis. Recently, a few studies have suggested that FMF is related to increased risk of atherosclerosis. Mean platelet volume (MPV) is a marker of platelet activation. Larger platelets are associated with increased atherosclerosis risk. The aim of the study is to evaluate levels of MPV in pediatric FMF patients during and between attacks. The study consisted of 48 patients during an attack (group 1), 63 patients in attack-free period (at least 2 weeks after an attack, group 2), and 49 healthy controls (group 3). Erythrocyte sedimentation rate, C-reactive protein, white blood cell count, platelet count (PLT), and MPV levels were retrospectively recorded from the computerized patient database. Mean platelet volume was significantly lower in FMF patients during attack than in attack-free period (p = 0.00); however, there was no difference among attack-free patients and healthy controls (p = 0.38). The mean platelet counts of FMF patients during attack were higher than the healthy controls (p = 0.02). There was an inverse correlation between MPV and mean PLT in the attack-free period (r = −446, p = 0.01). This study suggests that an early atherosclerosis marker, MPV, is not elevated in pediatric FMF patients on colchicine treatment.
Literatur
1.
Zurück zum Zitat Cassidy JT, Petty RE (2005) Periodic fever syndromes in children. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier, Philadelphia, pp 657–690 Cassidy JT, Petty RE (2005) Periodic fever syndromes in children. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier, Philadelphia, pp 657–690
2.
Zurück zum Zitat Zemer D, Revach M, Pras M et al (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. New Eng J Med 291:932–934PubMedCrossRef Zemer D, Revach M, Pras M et al (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. New Eng J Med 291:932–934PubMedCrossRef
3.
Zurück zum Zitat Zemer D, Pras M, Sohar E et al (1974) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. New Eng J Med 314:1001–1005 Zemer D, Pras M, Sohar E et al (1974) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. New Eng J Med 314:1001–1005
4.
Zurück zum Zitat Bagci S, Toy B, Tuzun A et al (2004) Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23:333–337PubMedCrossRef Bagci S, Toy B, Tuzun A et al (2004) Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23:333–337PubMedCrossRef
5.
Zurück zum Zitat Colglazier CL, Sutej PG (2005) Laboratory testing in the rheumatic diseases: a practical review. South Med J 98:185–191PubMedCrossRef Colglazier CL, Sutej PG (2005) Laboratory testing in the rheumatic diseases: a practical review. South Med J 98:185–191PubMedCrossRef
6.
Zurück zum Zitat Caliskan M, Gullu H, Yilmaz S et al (2007) Impaired coronary microvascular function in familial Mediterranean fever. Atherosclerosis 195:161–167CrossRef Caliskan M, Gullu H, Yilmaz S et al (2007) Impaired coronary microvascular function in familial Mediterranean fever. Atherosclerosis 195:161–167CrossRef
7.
Zurück zum Zitat Akdoğan M, Calguneri M, Yavuz B et al (2006) Are familial Mediterranean fever (FMF) patients at risk for atherosclerosis? Impaired endothelial function and increased intima media thickness. J Am Coll Cardiol 48:2351–2353PubMedCrossRef Akdoğan M, Calguneri M, Yavuz B et al (2006) Are familial Mediterranean fever (FMF) patients at risk for atherosclerosis? Impaired endothelial function and increased intima media thickness. J Am Coll Cardiol 48:2351–2353PubMedCrossRef
8.
Zurück zum Zitat Peru H, Altun B, Doğan M et al (2008) The evaluation of carotid intima-media thickness in children with familial Mediterranean fever. Clin Rheumatol 27:689–694PubMedCrossRef Peru H, Altun B, Doğan M et al (2008) The evaluation of carotid intima-media thickness in children with familial Mediterranean fever. Clin Rheumatol 27:689–694PubMedCrossRef
9.
Zurück zum Zitat Bilginer Y, Ozaltin F, Basaran C et al (2008) Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis. Rheumatol Int 28:1211–1216PubMedCrossRef Bilginer Y, Ozaltin F, Basaran C et al (2008) Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis. Rheumatol Int 28:1211–1216PubMedCrossRef
10.
Zurück zum Zitat Ross R (1986) The pathogenesis of atherosclerosis—an update. New Eng J Med 314:488–500PubMed Ross R (1986) The pathogenesis of atherosclerosis—an update. New Eng J Med 314:488–500PubMed
11.
Zurück zum Zitat Sarı I, Karaoglu O, Can G et al (2007) Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 26:1467–1473PubMedCrossRef Sarı I, Karaoglu O, Can G et al (2007) Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 26:1467–1473PubMedCrossRef
12.
Zurück zum Zitat Martin JF, Trowbridge EA, Salmon G et al (1983) The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 32:443–460PubMedCrossRef Martin JF, Trowbridge EA, Salmon G et al (1983) The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 32:443–460PubMedCrossRef
13.
Zurück zum Zitat Thompson CB, Eaton KA, Princiotta SM et al (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 50:509–519PubMedCrossRef Thompson CB, Eaton KA, Princiotta SM et al (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 50:509–519PubMedCrossRef
14.
Zurück zum Zitat Çoban E, Adanir H (2008) Platelet activation in patients with familial Mediterranean fever. Platelets 19:405–408PubMedCrossRef Çoban E, Adanir H (2008) Platelet activation in patients with familial Mediterranean fever. Platelets 19:405–408PubMedCrossRef
15.
Zurück zum Zitat Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef
16.
Zurück zum Zitat Pras E, Livneh A, Balow JE Jr et al (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216–219PubMedCrossRef Pras E, Livneh A, Balow JE Jr et al (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216–219PubMedCrossRef
17.
Zurück zum Zitat Seyahi E, Ugurlu S, Cumali R et al (2005) Subclinical atherosclerosis in familial Mediterranean fever. In: Proceedings of the 4th international congress on systemic auto-inflammatory diseases. FMF and Beyond, NIAMS, Bethesda, 6–10 November 2005 Seyahi E, Ugurlu S, Cumali R et al (2005) Subclinical atherosclerosis in familial Mediterranean fever. In: Proceedings of the 4th international congress on systemic auto-inflammatory diseases. FMF and Beyond, NIAMS, Bethesda, 6–10 November 2005
18.
Zurück zum Zitat Kaser A, Brandacher G, Steurer W et al (2001) Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98:2720–2725PubMedCrossRef Kaser A, Brandacher G, Steurer W et al (2001) Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98:2720–2725PubMedCrossRef
19.
Zurück zum Zitat van Gameren MM, Willemse PH, Mulder NH et al (1994) Effects of recombinant human interleukin-6 in cancer patients: a phase I–II study. Blood 84:1434–1441PubMed van Gameren MM, Willemse PH, Mulder NH et al (1994) Effects of recombinant human interleukin-6 in cancer patients: a phase I–II study. Blood 84:1434–1441PubMed
20.
Zurück zum Zitat Clarke D, Johnson PW, Banks RE et al (1996) Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood. Cytokine 8:717–723PubMedCrossRef Clarke D, Johnson PW, Banks RE et al (1996) Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood. Cytokine 8:717–723PubMedCrossRef
21.
Zurück zum Zitat Baykal Y, Saglam K, Yilmaz MI et al (2003) Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 22:99–101PubMedCrossRef Baykal Y, Saglam K, Yilmaz MI et al (2003) Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 22:99–101PubMedCrossRef
22.
Zurück zum Zitat Gang N, Drenth JP, Langevitz P et al (1999) Activation of the cytokine network in familial Mediterranean fever. Rheumatol 26:890–897 Gang N, Drenth JP, Langevitz P et al (1999) Activation of the cytokine network in familial Mediterranean fever. Rheumatol 26:890–897
Metadaten
Titel
Mean platelet volume in children with familial Mediterranean fever
verfasst von
Balahan Makay
Zeynep Türkyilmaz
Erbil Ünsal
Publikationsdatum
01.08.2009
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 8/2009
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1148-5

Weitere Artikel der Ausgabe 8/2009

Clinical Rheumatology 8/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.